Legrand growth in sales in the first-half of 2025: +15% excluding exchange-rate impact Organic growth of +10% in the second quarter alone, fueled by datacenters 2025 full-year sales target revised ...

During Q2 2025, nearly 46.63% of transactions within an approximately $81 billion portfolio—spanning residential, commercial, and business-purpose loans—were flagged for issues that posed a ...

Albert Benavente Taimanglo was sentenced to 18 months in federal prison, plus three years supervised released following his sentencing hearing on Friday in front of District Court of Guam Chief ...

Cloudbreak Pharma Inc. a clinical-stage ophthalmology company developing innovative therapies for ocular surface diseases, today announced positive topline results from its Phase 2 clinical trial ...

Invivoscribe Inc., a global leader in precision diagnostics and measurable residual disease (MRD) testing, is proud to support CERo Therapeutics Holdings, In ...

The Phase 1/2 first-in-human, open-label clinical study is designed to assess the safety, tolerability, and preliminary clinical activity of AVZO-1418/DB-1418 as a single agent and in combination ...

The Hungarian oil company, which faced criticism for maintaining strong reliance on Russian energy, sees a pipeline from the Ukrainian port of Odesa as its best bet at diversification.

Dirk Thye, M.D., Quince’s Chief Executive Officer and Chief Medical Officer, said, “The completion of enrollment in our pivotal Phase 3 NEAT clinical trial evaluating eDSP for the treatment of ...

A 3-star defensive back prospect has made his college decision, choosing a Big 12 school over Michigan State and others. Jaxson Gates, a native of La Verne, California, was at one time committed to ...

This week, Chiefs Wire's Ed Easton Jr. spoke to retired NFL safety Erik Coleman to discuss his support for Acclaimed car customizer and TV personality Will Castro's new show, Unique Academy, and his ...

Based on these positive Phase 2 results, Cloudbreak Pharma Inc. plans to advance CBT-004 into Phase 3 development and initiate discussions with the U.S. Food and Drug Administration (FDA) to establish ...